Active, not recruitingPhase 2NCT01917721

Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease

Studying Kawasaki disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hawaii Pacific Health
Principal Investigator
Andras Bratincsak, MD PhD
Hawaii Pacific Health
Intervention
Doxycycline(drug)
Enrollment
50 enrolled
Eligibility
21 years · All sexes
Timeline
2013 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01917721 on ClinicalTrials.gov

Other trials for Kawasaki disease

Additional recruiting or active studies for the same condition.

See all trials for Kawasaki disease →

← Back to all trials